Drogas fluidas: revisitando a antropologia dos fármacos
DOI:
https://doi.org/10.5007/2175-8034.2023.e91717Palavras-chave:
Fármacos, Eficácia, Regulamentação, Experimentos, Materialidade, CorposResumo
Esta revisa?o aborda um conjunto crescente de trabalhos situados na intersecc?a?o entre a antropologia e os estudos sociais da cie?ncia e tecnologia (CTS) que examinam como as drogas sa?o tornadas eficazes nos laborato?rios, em contextos terape?uticos e na vida cotidiana. Essa literatura ressalta como os interesses comerciais e as preocupac?o?es sociais modelam os tipos de efeitos farmace?uticos que sa?o colocados em pra?tica, e como certas efica?cias sa?o bloqueadas devido a questo?es morais. Os trabalhos reunidos aqui revelam como as instituic?o?es reguladoras e os atores envolvidos nas poli?ticas pu?blicas de sau?de tentam estabilizar as ac?o?es farmace?uticas. Ao mesmo tempo, nas linhas de frente do cuidado, farmace?uticos, trabalhadores da sau?de e usua?rios procuram ajustar as dosagens e as indicac?o?es, buscando adaptar as ac?o?es farmace?uticas a circunsta?ncias especi?ficas. No?s mostramos que na?o existe um objeto (farmace?utico) puro que precede sua socializac?a?o. Os fa?rmacos na?o sa?o “descobertos”; eles sa?o constitui?dos e reproduzidos em relac?a?o a contextos muta?veis. Esta revisa?o delineia cinco a?reas-chave nas pesquisas etnogra?ficas e nos estudos CTS que examinam tais drogas fluidas.
Referências
’T HOEN, E. TRIPS – pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. Chicago J. Int. Law, [s.l.], v. 4, n. 1, p. 27-46, 2002.
ADAMS, V. Metrics: What Counts in Global Health. Durham, NC: Duke Univ. Press, 2016.
AKRICH, M. The de-scription of technical objects. In: J. BIJKER, J.; LAW, W. (org.). Shaping Technology/Building Society – Studies in Sociotechnical Change. Cambridge, MA: MIT Press, 1992. p. 205-224.
AKRICH, M. Petite anthropologie du medicament. Tech. Cult., [s.l.], p. 25-26, 1995. APPLBAUM K. Getting to yes: corporate power and the creation of a psychopharmaceutical
blockbuster. Cult. Med. Psychiatry, [s.l.], v. 33, n. 2, p. 185-215, 2009.
APPLBAUM, K.; OLDANI, M. (org.). Introduction: Towards an era of bureaucratically controlled medical compliance? Special Issue: Towards Era Bureaucratically Control. Med. Compliance? Anthropol. Med., [s.l.], v.17, n. 2, p. 113-127, 2010.
BAGLIA, J. The Viagra Ad Venture: Masculinity, Marketing, and the Performance of Sexual Health. New York: Peter Lang, 2005.
BANERJEE, D. Markets and molecules: a pharmaceutical primer from the south. Med. Anthropol., [s.l.], v. 13, p. 1-18, 2016.
BARRY A. Pharmaceutical matters: the invention of informed materials. Theory Cult. Soc., [s.l.], v. 22, n. 1, p. 51-69, 2005.
BENSAUDE-VINCENT, B.; STENGERS, I. A History of Chemistry. Cambridge, MA: Harvard Univ. Press, 1996.
BERG, M.; MOL, A. Differences in Medicine: Unraveling Practices, Techniques, and Bodies. Durham, NC: Duke Univ. Press, 1998.
BIEHL, J. Pharmaceuticalization: AIDS treatment and global health politics. Anthropol. Q.,
[s.l.], v. 80, n. 4, p. 1.083-1.126, 2007.
BIEHL, J.; PETRYNA, A. When People Come First: Critical Studies in Global Health.
Princeton, NJ: Princeton Univ. Press, 2013.
BLAIKIE, C. Wish-fulfilling jewel pills: Tibetan medicines from exclusivity to ubiquity.
Anthropol. Med., [s.l.], v. 22, n. 1, p. 7-22, 2015.
BRIVES, C.; LE MARCIS, F.; SANABRIA, E. What’s in a context? Tenses and tensions in
evidence-based medicine. Med. Anthropol., [s.l.], v. 35, n. 4, p. 369-376, 2016.
CASSIER, M.; CORRÊA, M. Éloge de la copie: le reverse engineering des antirétroviraux contre le VIH/sida dans les laboratoires pharmaceutiques Brésiliens. Sci. Soc. Santé, [s.l.], v. 27, n. 3, p. 77-103, 2009.
CASSIER, M.; CORRÊA, M. Access to medicines in developing countries: ethical demands and moral economy. Dev. World Bioeth., [s.l.], v. 14, n. 2, p. ii-viii, 2014.
CHAPUT DE SAINTONGE, D.; HERXHEIMER, A. Harnessing placebo effects in health care. Lancet, [s.l.], v. 344, p. 995-998, 1994.
CONRAD, P. Identifying Hyperactive Children: The Medicalization of Deviant Behavior. Abingdon, UK: Routledge; Expand, 2006.
COUSINS, T. A mediating capacity: toward an anthropology of the gut. Med. Anthropol. Theory, [s.l.], v. 2, n. 2, p. 1-27, 2015a.
COUSINS, T. HIV and the remaking of hunger and nutrition in South Africa: biopolitical specification after apartheid. BioSocieties, [s.l.], v. 10, n. 2, p. 143-161, 2015b.
COUSINS, T. Antiretroviral therapy and nutrition in Southern Africa: citizenship and the grammar of hunger. Med. Anthropol., [s.l.], v. 35, n. 5, p. 433-446, 2016.
CRAIG, S. R. Healing Elements: Efficacy and the Social Ecologies of Tibetan Medicine. Berkeley; London: Univ. Calif. Press, 2012.
CROWLEY-MATOKA, M.; TRUE, G. No one wants to be the candy man: ambivalent medicalization and clinician subjectivity in pain management. Cult. Anthropol., [s.l.], v. 27, n. 4, p. 689-712, 2012.
DAS, V.; DAS, R. K. Pharmaceuticals in urban ecologies: the register of the local. In: PETRYNA, A.; KLEINMAN, A.; LAKOFF, A. (org.). Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke Univ. Press, 2006. p. 171-205.
DAVIS, C.; ABRAHAM, J. Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science. New York: Palgrave Macmillan, 2013.
DE ZORDO, S. The biomedicalisation of illegal abortion: the double life of misoprostol in Brazil. Hist. Cienc. Saúde – Manguinhos, Rio de Janeiro, v. 23, n. 2, p. 19-35, 2016.
DEGRANDPRE, R. The Cult of Pharmacology: How America Became the World’s Most Troubled Drug Culture. Durham, NC: Duke Univ. Press, 2006.
DESANTIS, A.; WEBB, E. M.; NOAR, S. M. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J. Am. Coll. Health, [s.l.], v. 57, n. 3,
p. 315-24, 2008.
DOSHI, P. et al. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ, [s.l.], v. 346, f2865, 2013.
DRONEY, D. Networking health: multi-level marketing of health products in Ghana. Anthropol. Med., [s.l.], v. 23, n.1, p. 1-13, 2016.
DUMIT, J. Drugs for Life: How Pharmaceutical Companies Define Our Health. Durham, NC: Duke Univ. Press, 2012.
DYKE, E. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore, MD: Johns
Hopkins Univ. Press, 2008.
ECKS, S. Eating Drugs: Psychopharmaceutical Pluralism in India. New York: NYU Press, 2013.
ECKS, S.; BASU, S. The unlicensed lives of antidepressants in India: generic drugs, unqualified practitioners, and floating prescriptions. Transcult. Psychiatry, [s.l.], v. 46, n. 1, p. 86-106, 2009.
EDMONDS, A.; SANABRIA, E. Medical borderlands: engineering the body with plastic surgery and hormonal therapies in Brazil. Anthropol. Med., [s.l.], v. 21, n. 2, p. 202-216, 2014.
EPSTEIN, S. Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley: Univ. Calif. Press, 1998.
EPSTEIN, S. Bodily differences and collective identities: the politics of gender and race in biomedical research in the United States. Body Soc., [s.l.], v. 10, n. 2, p. 183-203, 2004.
ETKIN, N. L. “Side effects”: cultural constructions and reinterpretations of western pharmaceuticals. Med. Anthropol. Q., [s.l.], v. 6, p. 99-113, 1992.
FORTUN, K. Ethnography in late industrialism. Cult. Anthropol., [s.l.], v. 27, n. 3, p. 446-64, 2012.
FORTUN, K. et al. Experimental ethnography online: the asthma files. Cult. Stud., [s.l.], v. 28, p. 632-642, 2014.
FRASER, M. Material theory: duration and the serotonin hypothesis of depression. Theory Cult. Soc., [s.l.], v. 20, n. 5, p. 1-26, 2003.
GARRIOTT, W.; RAIKHEL, E. Addiction in the making. Annu. Rev. Anthropol., [s.l.], v. 44, n. 2, p. 477-491, 2015.
GAUDILLIÈRE, J. Professional or industrial order? Patents, biological drugs, and pharmaceutical capitalism in early twentieth century Germany. Hist. Technol., [s.l.], v. 24, n. 2, p. 107-133, 2008.
GAUDILLIÈRE, J. P. L’industrialisation du médicament: une histoire de pratiques entre sciences, techniques, droit et médecine. Gesnerus, [s.l.], v. 64, p. 93-108, 2007.
GAUDILLIÈRE, J. P.; HESS, V. Ways of Regulating Drugs in the 19th and 20th Centuries. Basingstoke, UK: Palgrave Macmillan, 2013.
GEZON, L. Drug Effects: Khat in Biocultural and Socioeconomic Perspective. Walnut Creek, CA: Left Coast Press, 2012.
GOMART, E. Methadone: six effects in search of a substance. Soc. Stud. Sci., [s.l.], v. 32, n. 2, p. 93-135, 2002.
GOMART, E.; HENNION, A. A sociology of attachment: music amateurs, drug users. Sociol. Rev., [s.l.], v. 47(S1), p. 220-247, 1999.
GRANADO, S. et al. Appropriating “malaria”: local responses to malaria treatment and prevention in Abidjan, Côte d’Ivoire. Med. Anthropol., [s.l.], v. 30, n. 2, p. 102-121, 2011.
GREENE, J. Generic: The Unbranding of Modern Medicine. Baltimore, MD: Johns Hopkins Univ. Press, 2014.
GREENSLIT, N. Depression and consumption: psychopharmaceuticals, branding, and new identity practices. Cult. Med. Psychiatry, [s.l.], v. 29, n. 2, p. 477-502, 2005.
HARDON, A. Contesting contraceptive innovation – reinventing the script. Soc. Sci. Med., [s.l.], v. 62, n. 2, p. 614-627, 2006.
HARDON, A.; IDRUS, N. I. On Coba and Cocok: youth-led drug-experimentation in Eastern Indonesia. Anthropol. Med., [s.l.], v. 21, n. 2, p. 217-229, 2014.
HARDON, A.; IDRUS, N. I. Magic power: changing gender dynamics and sex-enhancement practices among youths in Makassar, Indonesia. Anthropol. Med., [s.l.], v. 22, n. 2, p. 49-63, 2015.
HARDON, A.; POOL, R. Anthropologists in global health experiments. Med. Anthropol., [s.l.], v. 35, n. 2, p. 447-451, 2016.
HARTLEY, H. The “pinking” of Viagra culture: drug industry efforts to create and repackage sex drugs for women. Sexualities, [s.l.], v. 9, n. 2, p. 363-378, 2006.
HAYDEN, C. A generic solution? Pharmaceuticals and the politics of the similar in Mexico. Curr. Anthropol., [s.l.], v. 48, n. 2, p. 475-495, 2007.
HAYDEN, C. Rethinking reductionism, or, the transformative work of making the same. Anthropol. Forum, [s.l.], v. 22, n. 3, p. 271-283, 2012.
HEALY, D. The new medical Oikumene. In: PETRYNA, A.; KLEINMAN, A.; LAKOFF, A. (org.). Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke Univ. Press, 2006. p. 61-84.
HEIMER, C. A. Inert facts and the illusion of knowledge: strategic uses of ignorance in HIV clinics. Econ. Soc., [s.l.], v. 41, n. 2, p. 17-41, 2012.
HELMAN, C. “Feed a cold, starve a fever” - folk models of infection in an English suburban community, and their relation to medical treatment. Cult. Med. Psychiatry, [s.l.], v. 2, n. 2, p. 107-137, 1978.
HENARE, A.; HOLBRAAD, M.; WASTELL, S. Thinking Through Things: Theorising Artefacts Ethnographically. London: Routledge, 2007.
HSU, E. Plants in medical practice and common sense: on the interface of ethnobotany and medical anthropology. In: HSU, E. Plants, Health and Healing: On the Interface of Ethnobotany and Medical Anthropology. New York; Oxford, UK: Berghahn, 2012. p. 1-48.
HSU, E. From social lives to playing fields: “the Chinese antimalarial” as artemisinin monotherapy, artemisinin combination therapy and qinghao juice. Anthropol. Med., [s.l.], v. 22, n. 2, p. 75-86, 2015.
HUNT, L. M.; ARAR, N. H. An analytical framework for contrasting patient and provider views of the process of chronic disease management. Med. Anthropol. Q., [s.l.], v. 15, n. 2, p. 347- 367, 2001.
INGOLD, T. Being Alive: Essays on Movement, Knowledge and Description. Abingdon, UK: Routledge, 2011.
INGOLD, T. Toward an ecology of materials. Annu. Rev. Anthropol., v. 41, p. 427-442, 2012. JENKINS J. H. (org.). Pharmaceutical Self: The Global Shaping of Experience in an Age of
Psychopharmacology. Santa Fe, NM: Sch. Adv. Res. Press, 2011.
KAHN, J. Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age. New York: Columbia Univ. Press, 2013.
KAMAT, V. R.; NICHTER, M. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc. Sci. Med., [s.l.], v. 47, p. 779-794, 1998.
KAPTCHUK, T., Miller F. Placebo effects in medicine. N. Engl. J. Med. [s.l.], v. 373, n. 2, p. 8-9, 2015.
KIRMAYER, L. J. Unpacking the placebo response: insights from ethnographic studies of healing. J. Mind-Body Regul., [s.l.], v. 1, n. 1, p. 112-124, 2011.
KNAAPEN, L. Evidence-based medicine or cookbook medicine? Addressing concerns over the standardization of care. Sociol. Compass, [s.l.], v. 8, n. 2, p. 823-836, 2014.
KOHN, E. How Forests Think: Toward an Anthropology Beyond the Human. Berkeley: Univ.
Calif. Press, 2013.
KOPYTOFF, I. The cultural biography of things: commoditization as process. In: KOPYTOFF, I. The Social Life of Things: Commodities in Cultural Perspective. Cambridge, UK: Cambridge Univ. Press, 1986. p. 64-94.
KYAKUWA, M.; HARDON, A. Concealment tactics among HIV-positive nurses in Uganda. Cult. Health Sex., [s.l.], v. 14 (Suppl. 1), p. S123-133, 2012.
LAI, L.; FARQUHAR, J. Nationality medicines in China: institutional rationality and healing charisma. Comp. Stud. Soc. Hist., [s.l.], v. 57, n. 2, p. 381-406, 2015.
LAKOFF, A. Adaptive will: the evolution of attention deficit disorder. J. Hist. Behav. Sci., [s.l.], v. 32, n. 2, p. 149-169, 2000.
LANDECKER, H. The metabolism of philosophy, in three parts. In: COOPER, I.; MALKMUS, B. F. (org.). Dialectic and Paradox: Configurations of the Third in Modernity. Bern, Switz.: Peter Lang, 2013. p. 193-224.
LANDECKER, H. Antibiotic resistance and the biology of history. Body Soc., [s.l.], v. 22, p. 19-52, 2015.
LANGLITZ, N. Neuropsychedelia: The Revival of Hallucinogen Research Since the Decade of the Brain. London: Univ. Calif. Press, 2012.
LANGLITZ, N. Is there a place for psychedelics in philosophy? Fieldwork in neuro-and perennial philosophy. Common Knowl, [s.l.], v. 22, n. 2, p. 373-384, 2016.
LANGWICK, S. A. Partial publics: the political promise of traditional medicine in Africa. Curr. Anthropol., [s.l.], v. 56, n. 2, p. 493-514, 2015.
LAPLANTE, J. Healing Roots: Anthropology in Life and Medicine. New York; Oxford, UK: Berghahn, 2015.
LATOUR, B. We Have Never Been Modern. Cambridge, MA: Harvard Univ. Press, 1993. LIVINGSTONE, J. Improvising Medicine: An African Oncology Ward in an Emerging Cancer
Epidemic. Durham, NC: Duke Univ. Press, 2012.
LOCK, M. M.; NGUYEN, V. K. An Anthropology of Biomedicine. Chichester, UK: Wiley- Blackwell, 2010.
MARCUS, G. E. Ethnography in/of the world system: the emergence of multi-sited ethnography. Annu. Rev. Anthropol., [s.l.], v. 24, p. 95-117, 1995.
MARKS, H. M. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990. Cambridge, UK: Cambridge Univ. Press, 2000.
MARTIN, E. The pharmaceutical person. BioSocieties, [s.l.], v. 1, n. 2, p. 273-287, 2006. MATTES, D. “We are just supposed to be quiet”: the production of adherence to antiretroviral
treatment in urban Tanzania. Med. Anthropol., [s.l.], v. 30, n. 2, p. 158-182, 2011. McGOEY L. Strategic unknowns: towards a sociology of ignorance. Econ. Soc., [s.l.], v. 41,
n. 2, p. 1-16, 2012.
MILLER, F.; COLLOCA, L.; KAPTCHUK, T. The placebo effect: illness and interpersonal
healing. Perspect. Biol. Med., [s.l.], v. 52, n. 2, p. 518-539, 2009.
MOERMAN, D. E. Against the “placebo effect”: a personal point of view. Complement. Ther.
Med., [s.l.], v. 21, n. 2, p. 125-130, 2013.
MOERMAN, D. E.; JONAS, W. B. Deconstructing the placebo effect and finding the meaning
response. Ann. Intern. Med., [s.l.], v. 136, n. 2, p. 471-476, 2002.
MOL, A. The Body Multiple: Ontology in Medical Practice. Durham, NC; London, UK: Duke Univ. Press, 2002.
MOL, A. The Logic of Care: Health and the Problem of Patient Choice. Abingdon, UK:
Routledge, 2008.
MONTOYA M. J. Bioethnic conscription: genes, race, and Mexicana/o ethnicity in diabetes
research. Cult. Anthropol. [s.l.], v. 221, p. 94-128, 2007.
MURPHY, M. Chemical regimes of living. Environ. Hist., [s.l.], v. 13, n. 4, p. 695-703, 2008.
MURPHY, M. Distributed reproduction. In: M. J. CASPER, M. J.; CURRAH, P. (org.). Corpus: An Interdisciplinary Reader on Bodies and Knowledg. Basingstoke, UK: Palgrave Macmillan, 2011. p. 21-28.
MYERS, N. Rendering Life Molecular: Models, Modelers, and Excitable Matter. Durham, NC/London, UK: Duke Univ. Press, 2015.
NADING, A. M. Local biologies, leaky things, and the chemical infrastructure of global health. Med. Anthropol., [s.l.], v. 36, p. 141-56, 2016.
NAKASSIS, C. V. Brands and their surfeits. Cult. Anthropol., [s.l.], v. 28, n. 2, p. 111-126, 2013.
NELSON, N. C. et al. Testing devices or experimental systems? Cancer clinical trials take the genomic turn. Soc. Sci. Med., [s.l.], v. 111, p. 74-83, 2014.
NICHTER, M.; VUCKOVIC, N. Agenda for an anthropology of pharmaceutical practice. Soc. Sci. Med., [s.l.], v. 39, n. 11, p. 1.509-1.525, 1994.
OLDANI, M. J. Thick prescriptions: toward an interpretation of pharmaceutical sales practices. Med. Anthropol. Q., [s.l.], v. 18, n. 2, p. 325-356, 2004.
ORAM, M. Efficacy and enlightenment: LSD psychotherapy and the Drug Amendments of 1962. J. Hist. Med. Allied Sci., [s.l.], v. 69, n. 2, p. 221-250, 2014.
PERSSON, A. et al. On the margins of pharmaceutical citizenship: not taking HIV medication in the “Treatment Revolution” era. Med. Anthropol. Q., [s.l.], v. 30, n. 2, p. 359-377, 2016.
PETERSON, K. Speculative Markets: Drug Circuits and Derivative Life in Nigeria. Durham, NC: Duke Univ. Press, 2014.
PETRYNA, A.; KLEINMAN, A.; LAKOFF, A. (org.). Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke Univ. Press, 2006.
POLLOCK, A. Medicating Race: Heart Disease and Durable Preoccupations with Difference. Durham, NC: Duke Univ. Press, 2012.
PORDIÉ, L. Hangover free! The social and material trajectories of PartySmart. Anthropol. Med. [s.l.], v. 22, n. 2, p. 34-48, 2015.
PORDIÉ, L.; HARDON, A. Drugs’ stories and itineraries. On the making of Asian industrial medicines. Anthropol. Med., [s.l.], v. 22, n. 2, p. 1-6, 2015.
POVINELLI, E. A. Geontologies: A Requiem to Late Liberalism. Durham, NC: Duke Univ. Press, 2016.
PRINCE, R.; GEISSLER, P. Knowledge of herbal and pharmaceutical medicines among Luo children in western Kenya. Anthropol. Med., [s.l.], v. 8, p. 211-35, 2001.
QUINTERO, G.; NICHTER, M. Generation RX: anthropological research on pharmaceutical enhancement, lifestyle regulation, self-medication and recreational drug use. In: M. SINGER, M.; ERICKSON, P. I. (org.). A Companion to Medical Anthropology. Oxford, UK: Wiley- Blackwell, 2011. p. 339-357.
RACE, K. Pleasure Consuming Medicine: The Queer Politics of Drugs. Durham, NC: Duke Univ. Press, 2009.
SAETHRE, E. J.; STADLER, J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol. Med., [s.l.], v. 17, n. 2, p. 99-111, 2010.
SANABRIA, E. Le médicament, un objet evanescent: essai sur la fabrication et la consommation des substances pharmaceutiques. Tech. Cult., [s.l.], v. 52-53, p. 168-189, 2009.
SANABRIA, E. “The same thing in a different box”: similarity and difference in pharmaceutical sex hormone consumption and marketing. Med. Anthropol. Q., [s.l.], v. 28, n. 2, p. 537-555, 2014.
SANABRIA, E. Plastic Bodies: Sex Hormones and Menstrual Suppression in Brazil. Durham, NC: Duke Univ. Press, 2016.
SISMONDO, S. Linking research and marketing, a pharmaceutical innovation. In: QUIRKE, V.; SLINN, J. (org.). Perspectives on Twentieth-Century Pharmaceuticals. Bern, Switz.: Peter Lang, 2010. p. 241-256.
SISMONDO, S. Pushing knowledge in the drug industry: ghost-managed science. In:
S. SISMONDO, S.; GREENE, J. A. (org.). The Pharmaceutical Studies Reader. Oxford, UK: Oxford Univ. Press, 2015. p. 150-164.
STRATHERN, M. Kinship, Law and the Unexpected: Relatives Are Always a Surprise. Cambridge, UK: Cambridge Univ. Press, 2005.
STRATHERN, M. Reading relations backwards. J. R. Anthropol. Inst., [s.l.], v. 20, n. 2, p. 3-19, 2014.
SUNDER RAJAN, K. Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine. Durham, NC: Duke. Univ. Press, 2017.
THOPMPSON, J. J.; RITENBAUGH, C.; NICHTER, M. Reconsidering the placebo response from a broad anthropological perspective. Cult. Med. Psychiatry, [s.l.], v. 33, n. 2, p. 112-152, 2009.
TRNKA, S. Domestic experiments: familial regimes of coping with childhood asthma in New Zealand. Med. Anthropol., [s.l.], v. 33, n. 2, p. 546-560, 2014.
VAN DER GEEST, S.; WHYTE, S. R. The charm of medicines: metaphors and metonyms. Med. Anthropol. Q., [s.l.], v. 3, n. 2, p. 345-367, 1989.
VAN DER GEEST, S.; WHYTE, S. R.; HARDON, A. The anthropology of pharmaceuticals: a biographical approach. Annu. Rev. Anthropol., [s.l.], v. 25, p. 153-178, 1996.
WAHLBERG, A. Herbs, laborkatories, and revolution: on the making of a national medicine in Vietnam. East Asian Sci. Technol. Soc., [s.l.], v. 8, n. 1, p. 43-56, 2014.
WALSH, V.; GOODMAN, J. From taxol to taxol®: the changing identities and ownership of an anti-cancer drug. Med. Anthropol. Cross-Cult. Stud. Health Illn., [s.l.], v, 21 n. 3-4, p. 307-336, 2002.
WENTZELL, E. Marketing silence, public health stigma and the discourse of risky gay Viagra use in the US. Body Soc., [s.l.], v. 17, n. 2, p. 105-125, 2011.
WHITMARSH, I. Biomedical Ambiguity: Race, Asthma, and the Contested Meaning of Genetic Research in the Caribbean. Ithaca, NY: Cornell Univ. Press, 2008.
WHYTE, S. R.; VAN DER GEEST, S.; HARDON A. Social Lives of Medicines. Camb. Stud. Med. Anthropol. Cambridge, UK: Cambridge Univ. Press, 2002.
WILLEMS, D. Susan’s breathlessness: the construction of professionals and lay persons. In: J. LACHMUND. J.; STOLLBERG, G. (org.). The Social Construction of Illness. Stuttgart, Ger.: Franz Steiner, 1992. p. 105-114.
WILSON, E. Gut Feminism. Durham, NC: Duke Univ. Press, 2015.
WINKELMAN, M. J.; ROBERTS, T. B. (org.). Psychedelic Medicine: New Evidence for
Hallucinogenic Substances as Treatments. Westport, CT: Praeger, 2007.
WOLF-MEYER, M. Therapy, remedy, cure: disorder and the spatiotemporality of medicine and everyday life. Med. Anthropol., [s.l.], v. 33, n. 2, p. 144-159, 2014.
WYNN, L. L.; TRUSSELL, J. The social life of emergency contraception in the United States: disciplining pharmaceutical use, disciplining sexuality, and constructing zygotic bodies. Med. Anthropol. Q., [s.l.], v. 20, n. 2, p. 297-320, 2006.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Ilha Revista de Antropologia
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Os autores cedem à Ilha – Revista de Antropologia – ISSN 2175-8034 os direitos exclusivos de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Atribuição Não Comercial Compartilhar Igual (CC BY-NC-SA) 4.0 International. Esta licença permite que terceiros remixem, adaptem e criem a partir do trabalho publicado, desde que para fins não comerciais, atribuindo o devido crédito de autoria e publicação inicial neste periódico desde que adotem a mesma licença, compartilhar igual. Os autores têm autorização para assumir contratos adicionais separadamente, para distribuição não exclusiva da versão do trabalho publicada neste periódico (ex.: publicar em repositório institucional, em site pessoal, publicar uma tradução, ou como capítulo de livro), com reconhecimento de autoria e publicação inicial neste periódico, desde que para fins não comerciais e compartilhar igual.
